Literature DB >> 25196736

Depression is not associated with peripheral insulin resistance in patients with chronic hepatitis C infection.

S C Shah1, J Kornak, M Khalili.   

Abstract

Depression is common in individuals infected with hepatitis C virus (HCV), and both depression and HCV infection are independently associated with insulin resistance (IR). To evaluate the relationship between depression and IR, among other factors, in an HCV-infected cohort. In this cross-sectional analysis, seventy-four non-type 2 diabetic, noncirrhotic, HCV-infected patients underwent comprehensive clinical, histologic and metabolic evaluation. IR was assessed directly with an insulin suppression test by measuring steady-state plasma glucose (SSPG) levels during continuous infusions of octreotide, glucose and insulin. Logistic regression modelling was used to evaluate predictors associated with depression. Thirty-nine (53%) patients were depressed, and 21 (54%) depressed patients were on at least one antidepressant. A higher estimated proportion of depressed patients were Caucasian (51% vs 20%, P = 0.005), unemployed (69% vs 49%, P = 0.07), heavier smokers (18 pack-years vs 13 pack-years, P = 0.07), on substance abuse therapy (16% vs 3%, P = 0.06) and had lower HDL levels (1.2 mmol/L vs 1.4 mmol/L, P = 0.01). The mean SSPG levels in depressed and nondepressed patients were 7.3 and 8.3 mmol/L (P = 0.45), respectively. In multipredictor adjusted analysis, only Caucasian race (OR 4.19, 95% CI 1.42-12.35, P = 0.009) and lower HDL (OR 0.95, 95% CI 0.89-0.99, P = 0.046) were associated with depression. In conclusion, although prevalent, depression was not associated with peripheral IR in this HCV-infected cohort. Attention to other modifiable factors associated with depression in the HCV-infected population is warranted.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  clamp studies; hepatitis C; impaired fasting glucose; impaired glucose tolerance; insulin resistance; neuropsychiatric

Mesh:

Substances:

Year:  2014        PMID: 25196736      PMCID: PMC4386832          DOI: 10.1111/jvh.12306

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  46 in total

Review 1.  How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli.

Authors:  S Rivest; S Lacroix; L Vallières; S Nadeau; J Zhang; N Laflamme
Journal:  Proc Soc Exp Biol Med       Date:  2000-01

2.  Upregulation of indoleamine 2,3-dioxygenase in hepatitis C virus infection.

Authors:  Esther Larrea; José I Riezu-Boj; Lucía Gil-Guerrero; Noelia Casares; Rafael Aldabe; Pablo Sarobe; María P Civeira; Jonathan L Heeney; Christine Rollier; Babs Verstrepen; Takaji Wakita; Francisco Borrás-Cuesta; Juan J Lasarte; Jesús Prieto
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

3.  Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin(1A) receptors.

Authors:  Sandeep Shrivastava; Thomas J Pucadyil; Yamuna Devi Paila; Sourav Ganguly; Amitabha Chattopadhyay
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

4.  Insulin resistance plays a significant role in liver fibrosis in chronic hepatitis C and in the response to antiviral therapy.

Authors:  R D'Souza; C A Sabin; G R Foster
Journal:  Am J Gastroenterol       Date:  2005-07       Impact factor: 10.864

Review 5.  Evidence for an immune response in major depression: a review and hypothesis.

Authors:  M Maes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1995-01       Impact factor: 5.067

Review 6.  Fibromyalgia, hepatitis C infection, and the cytokine connection.

Authors:  Mollie E Thompson; André Barkhuizen
Journal:  Curr Pain Headache Rep       Date:  2003-10

7.  Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture.

Authors:  Kyung-Soo Chang; Jieyun Jiang; Zhaohui Cai; Guangxiang Luo
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

8.  Diagnosis, management, and treatment of hepatitis C: an update.

Authors:  Marc G Ghany; Doris B Strader; David L Thomas; Leonard B Seeff
Journal:  Hepatology       Date:  2009-04       Impact factor: 17.425

9.  Insulin sensitivity and variability in hepatitis C virus infection using direct measurement.

Authors:  Nizar A Mukhtar; Peter Bacchetti; Claudia E Ayala; Jennifer Melgar; Spencer Christensen; Jacquelyn J Maher; Mandana Khalili
Journal:  Dig Dis Sci       Date:  2012-10-21       Impact factor: 3.199

10.  Differential cognitive impairment in HCV coinfected men with controlled HIV compared to HCV monoinfection.

Authors:  Bing Sun; Linda Abadjian; Hans Rempel; Alexander Monto; Lynn Pulliam
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

View more
  1 in total

1.  Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients.

Authors:  Mohammad-Ali Jenabian; Vikram Mehraj; Cecilia T Costiniuk; Kishanda Vyboh; Ido Kema; Kathleen Rollet; Robert Paulino Ramirez; Marina B Klein; Jean-Pierre Routy
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.